NINGBO INNO PHARMCHEM CO.,LTD. is proud to highlight the importance of 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one, a vital chemical compound that serves as a cornerstone in the synthesis of advanced pharmaceutical agents. Specifically, this compound, identified by its CAS number 199327-61-2, is a critical intermediate in the production of Gefitinib. Gefitinib is a revolutionary drug that has significantly impacted the treatment of certain types of cancer by targeting specific cellular pathways responsible for tumor growth and survival. Understanding the intricacies of Gefitinib synthesis is key to appreciating the value of high-quality intermediates like this quinazolinone derivative.

The chemical structure of this compound, C16H21N3O4, with a molecular weight of approximately 319.36, is meticulously designed to facilitate the complex organic synthesis required for producing potent and effective medications. Its role as a pharmaceutical intermediate means that its purity and consistency are paramount. At NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to ensuring that our supply of CAS 199327-61-2 meets the highest industry standards, supporting the development of life-saving drugs. The availability of reliable Gefitinib impurity suppliers is also crucial for maintaining the integrity of the final product, a commitment we uphold.

The strategic importance of 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one extends beyond its immediate application. It is a testament to the advancements in medicinal chemistry and the ongoing pursuit of targeted therapies. By providing this essential building block, NINGBO INNO PHARMCHEM CO.,LTD. contributes to the broader API manufacturing supply chain, enabling pharmaceutical companies to develop and deliver innovative treatments to patients worldwide. The ability to buy 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one from a trusted source like NINGBO INNO PHARMCHEM CO.,LTD. empowers researchers and manufacturers to advance their critical work in fighting diseases.

In essence, the journey from a chemical intermediate to a life-saving drug is a complex one, and compounds like 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one are the silent heroes of this process. Their precise chemical properties and reliable supply are foundational to the success of modern pharmaceutical development, particularly in the fight against cancer. The ongoing demand for high-purity intermediates underscores the dynamic nature of the API intermediate market and the crucial role played by specialized chemical manufacturers.